1-(3,4-dichlorophenyl)-3-[4-[3-(dimethylamino)propylamino]-6-methylpyrimidin-2-yl]urea
1-(3,4-dichlorophenyl)-3-[4-[3-(dimethylamino)propylamino]-6-methylpyrimidin-2-yl]urea
PubChem CID: 122520266
CT-179 is a member of the class of pyridines that is pyridine substituted by [(3,4-dichlorophenyl)carbamoyl]amino, [3-(dimethylamino)propyl]amino, and methyl groups at positions 2, 4 and 6, respectively. It is a small molecule inhibitor of OLIG2 developed by Curtana Pharmaceuticals for the treatment of glioblastoma, medulloblastoma, and other brain cancers. It has a role as an OLIG2 inhibitor and an antineoplastic agent. It is a member of phenylureas, a dichlorobenzene, a member of pyridines, a secondary amino compound and a tertiary amino compound.
Canonical SMILES
SMILES: CC1=CC(=NC(=N1)NC(=O)NC2=CC(=C(C=C2)Cl)Cl)NCCCN(C)CIsomeric SMILES
SMILES: CC1=CC(=NC(=N1)NC(=O)NC2=CC(=C(C=C2)Cl)Cl)NCCCN(C)CThis platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to CT-179